LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Ahmed-Jushuf, F; Jiwa, NS; Arwani, AS; Foot, P; Bridges, LR; Kalaria, RN; Esiri, MM; Hainsworth, AH (2016)
Publisher: Elsevier
Languages: English
Types: Article
Subjects:

Classified by OpenAIRE into

mesheuropmc: cardiovascular system
Vascular myocytes are central to brain aging. Small vessel disease (SVD; arteriolosclerosis)\ud is a widespread cause of lacunar stroke and vascular dementia, and is characterised by\ud fibrosis and depletion of vascular myocytes in small penetrating arteries. Vascular\ud endothelial growth factor (VEGF) is associated with brain aging, and VEGFR2 is a potent\ud determinant of cell fate. Here, we tested whether VEGFR2 in vascular myocytes is\ud associated with older age and SVD in human brain.\ud VEGFR2 immunolabelling in deep grey matter was assessed in older people with or without\ud moderate-severe SVD, or in younger people without brain pathology or with a monogenic\ud form of SVD (CADASIL). All cases were without Alzheimer’s disease pathology. Myocyte\ud VEGFR2 was associated with increasing age (p=0.0026) but not with SVD pathology or\ud with sclerotic index or blood vessel density. We conclude that VEGFR2 is consistently\ud expressed in small artery myocytes of older people, and may mediate effects of VEGF on\ud brain vascular aging.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • [1] Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci U S A 2009;106(6):1977-82.
    • [2] Argaw AT, Zhang Y, Snyder BJ, Zhao ML, Kopp N, Lee SC, Raine CS, Brosnan CF, John GR. IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J Immunol 2006;177(8):5574-84.
    • [3] Barker R, Ashby EL, Wellington D, Barrow VM, Palmer JC, Kehoe PG, Esiri MM, Love S. Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia. Brain 2014;137(Pt 5):1524-32.
    • [4] Boer K, Troost D, Spliet WG, van Rijen PC, Gorter JA, Aronica E. Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB. Acta Neuropathol 2008;115(6):683-96.
    • [5] Bridges LR, Andoh J, Lawrence AJ, Khoong CH, Poon WW, Esiri MM, Markus HS, Hainsworth AH. Blood-brain barrier dysfunction and cerebral small vessel disease (arteriolosclerosis) in brains of older people. J Neuropathol Exp Neurol 2014;73(11):1026-33.
    • [6] Brockington A, Wharton SB, Fernando M, Gelsthorpe CH, Baxter L, Ince PG, Lewis CE, Shaw PJ. Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2006;65(1):26-36.
    • [7] Chanakira A, Dutta R, Charboneau R, Barke R, Santilli SM, Roy S. Hypoxia differentially regulates arterial and venous smooth muscle cell proliferation via PDGFR-beta and VEGFR-2 expression. Am J Physiol Heart Circ Physiol 2012;302(5):H1173-H1184.
    • [8] Cheng C, Haasdijk RA, Tempel D, den Dekker WK, Chrifi I, Blonden LA, van de Kamp EH, de BM, Burgisser PE, Noorderloos A, Rens JA, ten Hagen TL, Duckers HJ. PDGF-induced migration of vascular smooth muscle cells is inhibited by heme oxygenase-1 via VEGFR2 upregulation and subsequent assembly of inactive VEGFR2/PDGFRbeta heterodimers. Arterioscler Thromb Vasc Biol 2012;32(5):1289-98.
    • [1] AndohJ,S aw yerB,S zew czykK,N ortley M ,R ossettiT ,L oftusIM ,Yanez-M unozR J,Hainsw orth AH.T ransgenedelivery toendothelialculturesderivedfrom porcinecarotidartery ex vivo. T ranslS trokeR es2013;4(5):507-14.
    • [2] BridgesL R ,AndohJ,L aw renceAJ,KhoongCH,P oonW W ,EsiriM M ,M arkusHS ,Hainsw orth AH.Blood-brainbarrierdysfunctionandcerebralsm allvesseldisease(arteriolosclerosis)in brainsofolderpeople.JN europatholExpN eurol2014;73(11):1026-33.
    • [3] Hainsw orthAH,Berm pohlD,W ebbT E,Darw ishR ,Fiskum G,Q iu J,M cCarthy D,M oskow itz M A,W halenM J.ExpressionofcellularFL ICEinhibitory proteins(cFL IP )innorm aland traum aticm urineandhum ancerebralcortex.JCerebBloodFlow M etab2005;25(8):1030-40.
  • No related research data.
  • No similar publications.

Share - Bookmark

Funded by projects

Cite this article